NRx Pharmaceuticals, Inc. (NRXP) Wins $11.18M DARPA Contract
NRx Pharmaceuticals’ subsidiary NRx Defense Systems received a $11,177,757 DARPA prime contract to evaluate robotic TMS with NRX-101 for treatment-resistant depression in a trial that will now begin enrolling.Material DetailsContext by AI AnalystThis is an early-stage but tangible funding and execu…